Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.

Congratulations Laura and Roger, and keep up the good work!

More details? Click here.

OTHER NEWS

News Awards

Spanish National Research Awards 2026

Two ICREA Research Professors received awards in the 'Premios Nacionales de Investigación 2026'. These awards, granted by the Ministry of…

News Awards

Banco Sabadell Foundation Awards 2026

ICREA researcher Marc Güell receives the 21st Banc Sabadell Foundation Award for Biomedical Research. The Banc Sabadell Foundation has recognised…